COVID Protection After Transplant-Immunosuppression Reduction
Clinical trial NCT05077254 · COMPLETED
Trial details
- NCT number
- NCT05077254
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2024-02-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.